POLYMORPHISM AND PERIPHERAL LEVELS OF APOLIPOPROTEIN(A) IN POLYGENIC HYPERCHOLESTEROLEMIA AND COMBINED HYPERLIPIDEMIA

被引:0
|
作者
SHEN, GX [1 ]
MYMIN, D [1 ]
DEMBINSKI, T [1 ]
KRAHN, A [1 ]
ANGEL, A [1 ]
机构
[1] UNIV MANITOBA,DEPT CLIN CHEM,WINNIPEG,MB R3E 3J7,CANADA
来源
CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE | 1995年 / 18卷 / 01期
关键词
APOLIPOPROTEIN(A); POLYGENIC HYPERCHOLESTEROLEMIA; COMBINED HYPERLIPIDEMIA;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This study demonstrates that peripheral apolipoprotein(a) [apo(a)] levels are higher in patients with polygenic hypercholesterolemia (PH) and combined hyperlipidemia (CH) than in controls. Levels of apo(a) inversely correlate with apo(a) isoform sizes. For a given apo(a) isoform, apo(a) levels are higher in PH and CH patients. Higher frequencies of smaller apo(a) isoforms were found in PH and CH patients than in controls, and in patients with coronary artery disease (CAD) or a family history of premature cardiovascular diseases than in patients without CAD or family history.
引用
收藏
页码:33 / 41
页数:9
相关论文
共 50 条
  • [1] Influence of the apolipoprotein B/apolipoprotein AI ratio on preclinical carotid atherosclerosis in familial combined hyperlipidemia and polygenic hypercholesterolemia
    Junyent, M.
    Gilabert, R.
    Nunez, I.
    Cofan, M.
    Zambon, D.
    Ros, E.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 112 - 112
  • [2] Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemia
    Emanuele, E
    Peros, E
    Minoretti, P
    D'Angelo, A
    Piccinni, MN
    Montagna, L
    Geroldi, D
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2004, 14 (04) : 193 - 199
  • [3] Apolipoprotein E genotype and cholesterogenesis in polygenic hypercholesterolemia
    Lala, A
    Scoppola, A
    Motti, C
    Cortese, C
    Caccese, D
    Menzinger, G
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1998, 47 (01): : 97 - 100
  • [4] Familial combined hyperlipidemia is a polygenic trait
    Gill, Praneet K.
    Hegele, Robert A.
    CURRENT OPINION IN LIPIDOLOGY, 2022, 33 (02) : 126 - 132
  • [5] APOLIPOPROTEIN-E POLYMORPHISM AND HYPERLIPIDEMIA
    ASSMANN, G
    SCHMITZ, G
    MENZEL, HJ
    SCHULTE, H
    CLINICAL CHEMISTRY, 1984, 30 (05) : 641 - 643
  • [6] Segregation analysis of plasma apolipoprotein B levels in familial combined hyperlipidemia
    Bredie, SJH
    vanDrongelen, J
    Kiemeney, LA
    Demacker, PNM
    Beaty, TH
    Stalenhoef, AFH
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (05) : 834 - 840
  • [7] BIMODALITY OF PLASMA APOLIPOPROTEIN-B LEVELS IN FAMILIAL COMBINED HYPERLIPIDEMIA
    AUSTIN, MA
    HOROWITZ, H
    WIJSMAN, E
    KRAUSS, RM
    BRUNZELL, J
    ATHEROSCLEROSIS, 1992, 92 (01) : 67 - 77
  • [8] Insulin resistance is associated with hypertriglyceridemia and combined hyperlipidemia but not with hypercholesterolemia in familial combined hyperlipidemia
    Pihlajamäki, J
    Karjalainen, L
    Laakso, M
    ATHEROSCLEROSIS, 1999, 144 : 12 - 12
  • [9] Apolipoprotein E polymorphism influences lipid phenotypes in Chinese families with familial combined hyperlipidemia
    Pei, Wei-Dong
    Zhang, Yan-Hong
    Sun, Yu-Hua
    Gu, Yu-Chun
    Wang, Yan-Fen
    Zhang, Chao-Yang
    Zhang, Jian
    Liu, Li-Sheng
    Hui, Ru-Tai
    Liu, Yu-Qing
    Yang, Yue-Jin
    CIRCULATION JOURNAL, 2006, 70 (12) : 1606 - 1610
  • [10] Apolipoprotein B metabolism in combined hyperlipidemia
    Shepherd, J
    ATHEROSCLEROSIS, 1998, 138 : S4 - S4